Physician profile
Roopali Aggrwal
NPI 1932249240
$2,061.65
in general payments reported to CMS, 2019-2025
7 companies · $33.96 in 2025
The $33.96 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.73 · 2020: $42.20 · 2021: $1,216 · 2022: $369 · 2024: $360 · 2025: $33.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $286 · Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $285.87 |
| Food and Beverage | $108.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $1,215.53 | 2021 | |
| Baxter Healthcare | $613.26 | 2022-2024 | Hillrom - Audioscope 3 |
| Pfizer INC. | $79.74 | 2019-2024 | |
| Sanofi Pasteur INC. | $73.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $36.04 | 2024 | Gardasil, Vaxneuvance, Gardasil 9 |
| Kaleo, INC. | $26.65 | 2019-2022 | |
| Glaxosmithkline, LLC. | $16.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roopali Aggrwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.